Biotechnology
Company Overview of Diatide, Inc.
Company Overview
As of October 22, 1999, Diatide, Inc. was acquired by Schering Berlin, Inc. Diatide, Inc. is a development stage specialty pharmaceutical company engaged in the discovery, development, and commercialization of patented, disease-specific imaging agents, and therapeutics drugs for life-threatening diseases and conditions. The company is headquartered at Londonderry, New Hampshire.
Nine Delta Drive
Londonderry, NH 03053
United States
88 Employees
Phone:
603-437-8970
Key Executives for Diatide, Inc.
Diatide, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Synthrx, Inc. | United States |
| Meda Pharmaceuticals, Inc. | United States |
| NeuroGenomeX, Inc. | United States |
| Avidia, Inc. | United States |
| Cystic Fibrosis Foundation Therapeutics Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Diatide, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
